论文部分内容阅读
目的 :评价肝素抑制后发性白内障的远期疗效。方法 :对 4 7例 (肝素组 2 4例、对照组 2 3例 )白内障囊外摘除及后房型人工晶状体植入术后的病例随访观察 2 4至 36个月、平均 2 6个月。结果 :肝素组的后囊混浊发生率为 1 7% ,明显低于对照组的 56 5% (P <0 0 1 ) ;肝素组的矫正视力为 0 65±0 2 2 ,明显高于对照组的矫正视力 0 33± 0 2 4 (P <0 0 5)。结论 :肝素抑制后发性白内障的远期效果是肯定的。
PURPOSE: To evaluate the long-term efficacy of heparin in the treatment of post-op cataract. Methods: A total of 47 cases (24 cases in heparin group and 23 cases in control group) underwent extracapsular cataract extraction and posterior chamber intraocular lens implantation were followed up for 24 to 36 months with an average of 26 months. Results: The incidence of posterior capsular opacification was 17% in the heparin group, which was significantly lower than 56 5% in the control group (P <0.01). The corrected visual acuity in the heparin group was 0 65 ± 0 2 2, which was significantly higher than that in the control group Corrected visual acuity was 0 33 ± 0 2 4 (P <0 05). Conclusion: The long-term effect of heparin in inhibiting the development of posterior cataracts is affirmed.